Diagnosis and treatment monitoring of breast cancer by TRS-21-6W
Not Applicable
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-jRCTs042210158
- Lead Sponsor
- Koizumi Kei
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
1.Female patients age 20 or older
2.Patients with an initial diagnosis of primary breast cancer (including bilateral breast cancer)
3 Patients scheduled neoadjuvant chemotherapy or endocrine therapy
4.Patients whose consent for this study has been obtained by signing the consent form.
Exclusion Criteria
1.Patients with photosensitivity
2.Patients who cannot keep the same posture for the measurement time (about 40 minutes)
3.Patients with obvious distant metastasis (lung metastasis, liver metastasis, bone metastasis, etc.)
4.Patients with recurrent breast cancer
5.Patients who are judged by the principal investigator (or sub-investigator) to be in a condition inappropriate for the participation in the study
Study & Design
- Study Type
- Other
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ongitudinal changes in optical data before neoadjuvant therapy and at early point of treatment, and changes in tumor size due to the therapy
- Secondary Outcome Measures
Name Time Method Relationship between optical data and MRI/CT and pathological results<br>Adverse events<br>Device deficiencies